Jae-Gook Shin, MD, PhD

Chair / Professor, Dept. of Pharmacology and Dept. of Clinical Pharmacology

Inje University College of Medicine and Inje University Busan Paik Hospital

Dr. Jae-Gook Shin is currently a Professor and Chair of the department of Pharmacology and Clinical Pharmacology and founding Director of the Pharmacogenomics Research Center at Inje University College of Medicine, Busan, Korea. He is also Director of the Center for Personalized Precision Medicine of Tuberculosis (cPMTb) at Inje University College of Medicine, which is funded by Korean Ministry of Science and ICT. He also founded and developed the clinical trial center in Inje University Busan Paik Hospital as a director and PI of Global Center of Excellence in Clinical Trials, funded by Korean Ministry of Health and Welfare.  He was PI of over 100 investigator or sponsor initiated clinical trials for drug development as well as for the clinical pharmacology researches.

Dr. Shin received MD degree in Inje University, PhD from Seoul National University (Korea), and did clinical pharmacology training in Georgetown University Medical Center (USA) as an Awardee of MSD International Fellowship granted by Merck foundation. He published 320 articles in international peer reviewed journals in the area of clinical pharmacology including pharmacogenomics and personalized medicine, clinical PK/PD, DMPK/ drug interaction, clinical trials in drug development etc. He is highly experienced in the clinical and translational science in pharmacogenomics and personalized medicine, and interested to the implementation of those principle to the clinical practice. He is now serving for SPMED Co., a venture company in Korea, as CEO. He is also invited guest or honorary professors in several Universities including Fudan University, China and Haiphong Medical and Pharmacy University, Vietnam. Dr. Shin has been served for the domestic or international professional societies/Communities such as KSCPT, Eastern Regional IRB, KoNECT, IUPHAR Clinical Division council and Pharmacogenomcis Committee etc.

Menu